← Back to Search

Cardiac Rehabilitation for Atrial Fibrillation

N/A
Waitlist Available
Research Sponsored by MultiCare Health System Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Documented diagnosis of Paroxysmal and persistent Atrial Fibrillation
Be older than 18 years old
Must not have
Does not speak English
Documented cardiovascular disease or pulmonary/respiratory disease that would qualify the patient for Cardiac, Pulmonary or Vascular Rehabilitation at a Pulse Heart Institute rehabilitation program
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months after the first intake appointment
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing an exercise program to see if it can help prevent a heart condition from coming back in patients who have had a specific treatment. The program aims to make the heart stronger and healthier through regular exercise. Researchers will check the patients periodically to see if the exercise helped.

Who is the study for?
This trial is for adults over 18 with Paroxysmal and persistent Atrial Fibrillation who've had an ablation procedure at least 2 weeks ago. Participants must be able to attend a cardiac rehab program thrice weekly for 12 weeks, follow medication therapy, and have no physical limitations or severe cognitive impairments that prevent exercise.
What is being tested?
The study tests if a supervised 12-week exercise-based cardiac rehabilitation program can reduce the recurrence of atrial fibrillation after an ablation procedure. Patients are randomly assigned to either this intervention group or a control group receiving usual care.
What are the potential side effects?
While not explicitly listed, potential side effects may include typical risks associated with exercise such as muscle strains, fatigue, shortness of breath during activity, and in rare cases, heart-related events especially given the patient population's underlying condition.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with Atrial Fibrillation that comes and goes or stays.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not speak English.
Select...
I have heart or lung disease that qualifies me for a rehabilitation program.
Select...
I have been diagnosed with dementia or have cognitive issues.
Select...
I cannot do rehab exercises because of my physical condition.
Select...
I have had more than one ablation procedure.
Select...
I have had atrial fibrillation for a long time.
Select...
I have had a procedure to isolate the posterior wall of my heart.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months after the first intake appointment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months after the first intake appointment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
The aim of this study is to examine the effect of a 12-week exercise-based cardiac rehabilitation intervention on the recurrence of atrial fibrillation (AF) in 40 patients at six- and twelve-months post-ablation procedure.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: cardiac rehabilitation intervention groupExperimental Treatment1 Intervention
Participants assigned to the intervention group will participate in pre-post assessments and a 12-week supervised exercise based cardiac rehabilitation program at a designated local Pulse Heart Institute Cardiac Rehabilitation program.
Group II: control groupActive Control1 Intervention
Participants assigned to the control group will participate in pre-post assessments and will maintain usual care and current activity levels.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Exercise-based cardiac rehabilitation improves cardiovascular health through structured physical activity, which enhances heart function and reduces inflammation. This is particularly beneficial for AF patients as it can help maintain sinus rhythm and improve overall heart health. Other common treatments for AF include rate control, which uses medications like beta-blockers to maintain a heart rate below 85 beats per minute, and rhythm control, which aims to restore normal heart rhythm through electrical or pharmacologic cardioversion. Anticoagulation therapy is also crucial to prevent stroke by reducing the risk of blood clot formation. Together, these treatments help manage symptoms, reduce complications, and improve the quality of life for AF patients.

Find a Location

Who is running the clinical trial?

MultiCare Health System Research InstituteLead Sponsor
12 Previous Clinical Trials
986 Total Patients Enrolled

Media Library

12-week supervised exercise based cardiac rehabilitation program Clinical Trial Eligibility Overview. Trial Name: NCT05450731 — N/A
Atrial Fibrillation Research Study Groups: control group, cardiac rehabilitation intervention group
Atrial Fibrillation Clinical Trial 2023: 12-week supervised exercise based cardiac rehabilitation program Highlights & Side Effects. Trial Name: NCT05450731 — N/A
12-week supervised exercise based cardiac rehabilitation program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05450731 — N/A
~12 spots leftby Nov 2025